LGND
Price
$114.15
Change
-$1.54 (-1.33%)
Updated
Jun 27 closing price
Capitalization
2.2B
43 days until earnings call
ROIV
Price
$11.39
Change
-$0.21 (-1.81%)
Updated
Jun 27 closing price
Capitalization
7.74B
50 days until earnings call
Interact to see
Advertisement

LGND vs ROIV

Header iconLGND vs ROIV Comparison
Open Charts LGND vs ROIVBanner chart's image
Ligand Pharmaceuticals
Price$114.15
Change-$1.54 (-1.33%)
Volume$327.87K
Capitalization2.2B
Roivant Sciences
Price$11.39
Change-$0.21 (-1.81%)
Volume$11.13M
Capitalization7.74B
LGND vs ROIV Comparison Chart in %
Loading...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGND vs. ROIV commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGND is a Buy and ROIV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (LGND: $114.15 vs. ROIV: $11.39)
Brand notoriety: LGND and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGND: 262% vs. ROIV: 182%
Market capitalization -- LGND: $2.2B vs. ROIV: $7.74B
LGND [@Biotechnology] is valued at $2.2B. ROIV’s [@Biotechnology] market capitalization is $7.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGND’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • LGND’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than LGND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGND’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 3 bullish TA indicator(s).

  • LGND’s TA Score: 4 bullish, 6 bearish.
  • ROIV’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than LGND.

Price Growth

LGND (@Biotechnology) experienced а +0.07% price change this week, while ROIV (@Biotechnology) price change was -0.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

LGND is expected to report earnings on Aug 11, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.74B) has a higher market cap than LGND($2.2B). LGND has higher P/E ratio than ROIV: LGND (46.19) vs ROIV (1.97). LGND YTD gains are higher at: 6.533 vs. ROIV (-3.719). LGND has higher annual earnings (EBITDA): -122.1M vs. ROIV (-1.1B). ROIV has more cash in the bank: 4.89B vs. LGND (209M). LGND has less debt than ROIV: LGND (4.45M) vs ROIV (100M). LGND has higher revenues than ROIV: LGND (181M) vs ROIV (29.1M).
LGNDROIVLGND / ROIV
Capitalization2.2B7.74B28%
EBITDA-122.1M-1.1B11%
Gain YTD6.533-3.719-176%
P/E Ratio46.191.972,350%
Revenue181M29.1M622%
Total Cash209M4.89B4%
Total Debt4.45M100M4%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LGNDROIV
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
63%
Advances
ODDS (%)
Bullish Trend 19 days ago
73%
Bullish Trend 10 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 14 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
62%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCIKX17.420.21
+1.22%
NYLI PineStone International Eq Inv Cl
CIUEX13.030.13
+1.01%
Six Circles International Uncon Eq
MMIAX8.420.08
+0.96%
MassMutual International Eq A
TSNRX20.710.17
+0.83%
Touchstone Sands Capital Select Gr R6
RYOTX10.980.01
+0.09%
Royce Micro-Cap Invmt

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with ACLX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-1.33%
ACLX - LGND
48%
Loosely correlated
+0.90%
CRNX - LGND
47%
Loosely correlated
-0.10%
ROIV - LGND
47%
Loosely correlated
-1.81%
CRSP - LGND
47%
Loosely correlated
N/A
DNLI - LGND
46%
Loosely correlated
-2.69%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-1.81%
IMVT - ROIV
62%
Loosely correlated
N/A
ACLX - ROIV
52%
Loosely correlated
+0.90%
CRNX - ROIV
51%
Loosely correlated
-0.10%
KRYS - ROIV
51%
Loosely correlated
-2.60%
CGON - ROIV
50%
Loosely correlated
-0.46%
More